Cargando…
Serum Soluble Interleukin-2 Receptor Does Not Differentiate Complex Regional Pain Syndrome from Other Pain Conditions in a Tertiary Referral Setting
Previously, we showed that serum soluble interleukin-2 receptor (sIL-2R) levels, a marker for T-cell activation, were higher in complex regional pain syndrome (CRPS) patients than in healthy controls, suggesting pathogenic T-cell activation in CRPS. Additionally, sIL-2R levels discriminated well bet...
Autores principales: | Bharwani, K. D., Dirckx, M., Stronks, D. L., Dik, W. A., Huygen, F. J. P. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539124/ https://www.ncbi.nlm.nih.gov/pubmed/33061828 http://dx.doi.org/10.1155/2020/6259064 |
Ejemplares similares
-
Is there an association between serum soluble interleukin-2 receptor levels and syndrome severity in persistent Complex Regional Pain Syndrome?
por: Mangnus, Thomas J P, et al.
Publicado: (2023) -
Highlighting the Role of Biomarkers of Inflammation in the Diagnosis and Management of Complex Regional Pain Syndrome
por: Bharwani, Krishna D., et al.
Publicado: (2019) -
Elevated Plasma Levels of sIL-2R in Complex Regional Pain Syndrome: A Pathogenic Role for T-Lymphocytes?
por: Bharwani, Krishna D., et al.
Publicado: (2017) -
Effect of intravenous low‐dose S‐ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study
por: Mangnus, Thomas J. P., et al.
Publicado: (2021) -
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome
por: Mangnus, Thomas J. P., et al.
Publicado: (2022)